Hassiba Oubraham

1.2k total citations
25 papers, 873 citations indexed

About

Hassiba Oubraham is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hassiba Oubraham has authored 25 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Ophthalmology, 17 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Hassiba Oubraham's work include Retinal Diseases and Treatments (20 papers), Retinal Imaging and Analysis (16 papers) and Retinal and Optic Conditions (13 papers). Hassiba Oubraham is often cited by papers focused on Retinal Diseases and Treatments (20 papers), Retinal Imaging and Analysis (16 papers) and Retinal and Optic Conditions (13 papers). Hassiba Oubraham collaborates with scholars based in France and Italy. Hassiba Oubraham's co-authors include Salomon Y. Cohen, Eric H. Souied, Oudy Semoun, Giuseppe Querques, Alexandra Mière, G. Mimoun, Stéphane Quéré, Ala’a El Ameen, Ramin Tadayoni and Alain Zourdani and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and Retina.

In The Last Decade

Hassiba Oubraham

25 papers receiving 829 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hassiba Oubraham 836 700 96 47 21 25 873
Franck Fajnkuchen 894 1.1× 747 1.1× 60 0.6× 11 0.2× 34 1.6× 65 933
Luna Xu 563 0.7× 477 0.7× 57 0.6× 18 0.4× 20 1.0× 12 603
Kavita V. Bhavsar 1.0k 1.2× 674 1.0× 119 1.2× 54 1.1× 19 0.9× 23 1.1k
Sucharita Boddu 481 0.6× 415 0.6× 56 0.6× 14 0.3× 18 0.9× 13 522
DANIELLE L.L. COSTA 895 1.1× 403 0.6× 98 1.0× 38 0.8× 33 1.6× 12 919
Chris Or 297 0.4× 240 0.3× 72 0.8× 55 1.2× 19 0.9× 22 424
Rossella D’Aloisio 535 0.6× 413 0.6× 107 1.1× 30 0.6× 39 1.9× 66 649
Jonathan Shahar 372 0.4× 258 0.4× 79 0.8× 18 0.4× 25 1.2× 10 418
Kenneth T. Eng 656 0.8× 406 0.6× 92 1.0× 10 0.2× 19 0.9× 30 734
Jorge A. Fortun 586 0.7× 453 0.6× 57 0.6× 48 1.0× 27 1.3× 40 644

Countries citing papers authored by Hassiba Oubraham

Since Specialization
Citations

This map shows the geographic impact of Hassiba Oubraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassiba Oubraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassiba Oubraham more than expected).

Fields of papers citing papers by Hassiba Oubraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassiba Oubraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassiba Oubraham. The network helps show where Hassiba Oubraham may publish in the future.

Co-authorship network of co-authors of Hassiba Oubraham

This figure shows the co-authorship network connecting the top 25 collaborators of Hassiba Oubraham. A scholar is included among the top collaborators of Hassiba Oubraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassiba Oubraham. Hassiba Oubraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Salomon Y., Florence Coscas, Céline Faure, et al.. (2022). Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(4). 959–969. 2 indexed citations
2.
3.
Mière, Alexandra, et al.. (2019). Long-term follow up or macular neovascularization using optical coherence tomography angiography: Pro Re Nata versus Treat&Extend regimens. Investigative Ophthalmology & Visual Science. 60(9). 124–124. 1 indexed citations
4.
Cohen, Salomon Y., Laurent Kodjikian, François Devin, et al.. (2019). Avis d’experts : actualisation des bonnes pratiques des injections intravitréennes. Recommandations de la Société française d’ophtalmologie et de la Société française d’hygiène hospitalière. Journal Français d Ophtalmologie. 43(1). 59–62. 6 indexed citations
5.
Mière, Alexandra, Hassiba Oubraham, Francesca Amoroso, et al.. (2018). Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen. Journal of Ophthalmology. 2018. 1–7. 28 indexed citations
6.
Oubraham, Hassiba, et al.. (2016). Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(4). 743–751. 9 indexed citations
7.
8.
Mière, Alexandra, Oudy Semoun, Salomon Y. Cohen, et al.. (2015). OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION. Retina. 35(11). 2275–2284. 89 indexed citations
9.
Ameen, Ala’a El, Salomon Y. Cohen, Oudy Semoun, et al.. (2015). TYPE 2 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 35(11). 2212–2218. 107 indexed citations
10.
Kodjikian, Laurent, Florence Coscas, Stéphane Dumas, et al.. (2015). Traitement de la dégénérescence maculaire liée à l’âge : avis d’experts et algorithme thérapeutique. Journal Français d Ophtalmologie. 38(7). 639–645. 5 indexed citations
11.
Cohen, Salomon Y., Oudy Semoun, Olivia Zambrowski, et al.. (2015). Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice. Graefe s Archive for Clinical and Experimental Ophthalmology. 254(4). 639–644. 26 indexed citations
12.
Zerbib, Jennyfer, et al.. (2015). UNUSUAL RETINOPATHY ASSOCIATED WITH HEMOCHROMATOSIS. Retinal Cases & Brief Reports. 9(2). 190–194. 10 indexed citations
13.
Puche, Nathalie, Giuseppe Querques, Rocío Blanco-Garavito, et al.. (2014). Gray Hyper-Reflective Subretinal Exudative Lesions in Exudative Age-Related Macular Degeneration. American Journal of Ophthalmology. 158(2). 354–361. 31 indexed citations
14.
Bonnet, Clémence, Giuseppe Querques, Jennyfer Zerbib, et al.. (2014). HYPERREFLECTIVE PYRAMIDAL STRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY IN GEOGRAPHIC ATROPHY AREAS. Retina. 34(8). 1524–1530. 21 indexed citations
15.
Cohen, Salomon Y., G. Mimoun, Hassiba Oubraham, et al.. (2012). CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE. Retina. 33(3). 474–481. 166 indexed citations
16.
Cohen, Salomon Y., Hassiba Oubraham, Joël Uzzan, Lise Dubois, & Ramin Tadayoni. (2012). CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS. Retina. 32(8). 1480–1485. 46 indexed citations
17.
Oubraham, Hassiba, et al.. (2010). INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED. Retina. 31(1). 26–30. 127 indexed citations
18.
Cohen, S.Y., et al.. (2010). Impact des habitudes nutritionnelles sur la pathologie maculaire évalué par mesure de la densité optique du pigment maculaire. Journal Français d Ophtalmologie. 33(4). 234–240. 1 indexed citations
19.
Souied, Eric H., Nathanaël Benhamou, M Sterkers, et al.. (2001). Retinal Degeneration Associated With Congenital Transcobalamin II Deficiency. Archives of Ophthalmology. 119(7). 1076–1076. 6 indexed citations
20.
Glacet–Bernard, A., et al.. (1999). [Sarcoid optic neuropathy].. PubMed. 22(10). 1072–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franck Fajnkuchen Breakdown of academic impact, for papers by Luna Xu Breakdown of academic impact, for papers by Kavita V. Bhavsar Breakdown of academic impact, for papers by Sucharita Boddu Breakdown of academic impact, for papers by DANIELLE L.L. COSTA Breakdown of academic impact, for papers by Chris Or Breakdown of academic impact, for papers by Rossella D’Aloisio Breakdown of academic impact, for papers by Jonathan Shahar Breakdown of academic impact, for papers by Kenneth T. Eng Breakdown of academic impact, for papers by Jorge A. Fortun
Rankless by CCL
2026